My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Masimo Corporation - Common Stock (NQ:MASI)

175.62 +0.94 (+0.54%)

Streaming Delayed Price Updated: 2:02 PM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Apple Restores Blood-Oxygen Tracking To Watch After Customs Ruling — Masimo Strikes Back With Lawsuit Over Patent Rights ↗

August 21, 2025

Apple reintroduced blood-oxygen tracking on its watches after a Customs ruling, but Masimo has sued to block the feature again.

Via Benzinga

Topics Intellectual Property Lawsuit

Apple’s Watch War Heats Up: Masimo Takes Customs To Court Over Blood-Oxygen Feature ↗

August 20, 2025

Via Stocktwits

Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters

August 19, 2025

From Masimo

Via Business Wire

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Is the Market Bullish or Bearish on Masimo? ↗

July 24, 2025

Via Benzinga

How Do Investors Really Feel About Masimo? ↗

June 25, 2025

Via Benzinga

Here's How Much $100 Invested In Masimo 15 Years Ago Would Be Worth Today ↗

June 02, 2025

Via Benzinga

3 Unprofitable Stocks That Fall Short

August 15, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling ↗

August 14, 2025

Apple to roll out redesigned Blood Oxygen feature for select U.S. Apple Watch models via software update, following a favorable customs ruling.

Via Benzinga

Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Economy

Is the Market Bullish or Bearish on Masimo? ↗

May 28, 2025

Via Benzinga

MASI Q2 Deep Dive: Margin Expansion Amid Tariff Pressures and Strategic Leadership Changes

August 12, 2025

Medical tech company Masimo (NASDAQ:MASI) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.9% year on year to $370.9 million. The company expects the full year’s...

Via StockStory

Topics World Trade

Q2 Earnings Highlights: Masimo (NASDAQ:MASI) Vs The Rest Of The Patient Monitoring Stocks

August 11, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q2, starting with Masimo...

Via StockStory

Topics Artificial Intelligence

Masimo’s (NASDAQ:MASI) Q2: Beats On Revenue But Stock Drops

August 05, 2025

Medical tech company Masimo (NASDAQ:MASI) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.9% year on year to $370.9 million. The company expects the full year’s...

Via StockStory

Topics World Trade

Masimo Reports Second Quarter 2025 Results

August 05, 2025

From Masimo Corporation

Via Business Wire

Masimo (MASI) Reports Q2: Everything You Need To Know Ahead Of Earnings

August 03, 2025

Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings this Tuesday afternoon. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence Economy World Trade

1 Healthcare Stock to Consider Right Now and 2 That Underwhelm

July 31, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Via StockStory

Topics Stocks

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗

July 24, 2025

Via Benzinga

Masimo to Report Second Quarter 2025 Financial Results after Market Close on Tuesday, August 5

July 22, 2025

From Masimo

Via Business Wire

Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know

July 11, 2025

A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.

Via StockStory

Topics ETFs Stocks World Trade

Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years ↗

July 08, 2025

Via Benzinga

Masimo Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

July 08, 2025

From Masimo

Via Business Wire

Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years ↗

June 12, 2025

Via Benzinga

3 Unprofitable Stocks with Questionable Fundamentals

June 11, 2025

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

Via StockStory

New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

June 10, 2025

From Masimo

Via Business Wire

MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties

June 04, 2025

From Johnson Fistel, PLLP

Via Business Wire

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

June 02, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Masimo (NASDAQ:MASI) and the...

Via StockStory

Topics Artificial Intelligence

Masimo to Present in the Jefferies Global Healthcare Conference

May 27, 2025

From Masimo

Via Business Wire

MASI Q1 Earnings Call: Revenue Tops Expectations, Focus Shifts to Healthcare Core Amid Tariff Headwinds

May 19, 2025

Medical tech company Masimo (NASDAQ:MASI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.5% year on year to $372 million. The company expects the full year’s...

Via StockStory

Topics World Trade

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗

May 07, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.